print small

Participating Countries:

Algeria

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Bulgaria

Croatia

Czech Republic

Denmark

Finland

France

FYR of Macedonia

Germany

Greece

Iceland

Ireland

Israel

Italy

Lithuania

Morocco

Netherlands

New Zealand

Poland

Portugal

Romania

Russian Federation

Serbia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States

Member area provided by LTFE
COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST
25/10/2012 (Added to site)
Author(s): Teissie, J.; Escoffre, J. M.; Paganin, A.; Chabot, S.; Bellard, E.; Wasungu, L.; Rols, M. P.; Golzio, M.

Drug delivery by electropulsation: Recent developments in oncology

Journal: International Journal of Pharmaceutics, 423 (2012), pp. 3-6
DOI: 10.1016/j.ijpharm.2011.09.038
Request reprint  |  Tell your friend  | 

Abstract: Electro-permeabilisation allows the free access of polar compounds to the cytoplasm by a reversible alteration of the cell membrane. It is now used in clinics for the eradication of cutaneous solid tumors. New developments predict its future applications for other anti-cancer treatments.



Project Office

Working groups

Steering Committee

Founding members

DC Rapporteurs

Related sites: